Cargando…

Determining sensitivity to rapamycin and its analogues in breast cancer patients

Detalles Bibliográficos
Autor principal:	Witton, Caroline J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064119/ https://www.ncbi.nlm.nih.gov/pubmed/15642182 http://dx.doi.org/10.1186/bcr985

Ejemplares similares

Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion
por: Witton, Caroline J
Publicado: (2003)

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
por: Meyer, Dominique S, et al.
Publicado: (2010)

To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression
por: Watters, Rebecca J, et al.
Publicado: (2012)

Microarray technology and its effect on breast cancer (re)classification and prediction of outcome
por: Cardoso, Fatima
Publicado: (2003)

A prophylactic vaccine for breast cancer?
por: Watson, Christine J, et al.
Publicado: (2010)

Flexibilization of Fasting for Laboratory Determination of the Lipid Profile in Brazil: Science or Convenience?
por: de Cordova, Caio Maurício Mendes, et al.
Publicado: (2018)

Neoadjuvant chemotherapy: practice and thinking for Chinese patients with early breast cancer
por: Wang, Xue-Fei, et al.
Publicado: (2020)

Unmet Care Needs and Uncertainty in Patients Newly Diagnosed with Breast Cancer
por: Chen, Li-Wei, et al.
Publicado: (2022)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

Elf5 - breast cancer's little helper
por: Frend, Hayley T, et al.
Publicado: (2013)

Are breast cancers driven by fusion genes?
por: Edwards, Paul AW, et al.
Publicado: (2012)

Amping up estrogen receptors in breast cancer
por: Fowler, Amy M, et al.
Publicado: (2007)

Introducing the concept of breast cancer stem cells
por: Waterworth, Alison
Publicado: (2004)

Tracking the genomic evolution of breast cancer metastasis
por: Zecchin, Davide, et al.
Publicado: (2010)

Par-4 prevents breast cancer recurrence
por: Hebbar, Nikhil, et al.
Publicado: (2013)

Impact of microbiota on breast cancer hormone therapy
por: Terrisse, Safae, et al.
Publicado: (2023)

Breast cancer brain metastases: evidence for neuronal-like adaptation in a ‘breast-to-brain’ transition?
por: Van Swearingen, Amanda ED, et al.
Publicado: (2014)

New insights into signalling networks regulating breast cancer stem cells
por: Swarbrick, Alexander, et al.
Publicado: (2012)

PTHrP and breast cancer: more than hypercalcemia and bone metastases
por: Boras-Granic, Kata, et al.
Publicado: (2012)

Who's driving anyway? Herculean efforts to identify the drivers of breast cancer
por: Hartmaier, Ryan J, et al.
Publicado: (2012)

Mammographic density as a mediator for breast cancer risk: analytic approaches
por: VanderWeele, Tyler J, et al.
Publicado: (2012)

The role of single nucleotide polymorphisms in breast cancer metastasis
por: Rae, James M, et al.
Publicado: (2008)

Breast cancer metastasis: a microRNA story
por: Negrini, Massimo, et al.
Publicado: (2008)

Cannibalism, cell survival, and endocrine resistance in breast cancer
por: Clarke, Robert
Publicado: (2011)

BRCA1: linking HOX to breast cancer suppression
por: Jin, Kideok, et al.
Publicado: (2010)

BOLERO-2 - will this change practice in advanced breast cancer?
por: Johnston, Stephen RD
Publicado: (2012)

The breast cancer somatic 'muta-ome': tackling the complexity
por: Teschendorff, Andrew E, et al.
Publicado: (2009)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer
por: Tran, Lesa A, et al.
Publicado: (2011)

Cell fate takes a slug in BRCA1-associated breast cancer
por: Lindeman, Geoffrey J, et al.
Publicado: (2011)

Oncologic Imaging in Patients Undergoing Breast Reduction
por: Shah, Ajul, et al.
Publicado: (2016)

Cancer dormancy: time to explore its clinical relevance
por: Gužvić, Miodrag, et al.
Publicado: (2013)

Obesity hormone leptin: a new target in breast cancer?
por: Surmacz, Eva
Publicado: (2007)

A quantum leap in our knowledge of breast cancer mutations
por: Caldas, Carlos, et al.
Publicado: (2006)

Location, location, location: regulation of breast cancer progression by the microenvironment
por: Lee, Adrian V
Publicado: (2004)

Aspirin and breast cancer prevention – a link to ER status
por: Tait, Catherine R
Publicado: (2004)

Targeting breast cancer stem cells: fishing season open!
por: Ginestier, Christophe, et al.
Publicado: (2010)

Prognostic signatures in breast cancer: correlation does not imply causation
por: Ng, Charlotte, et al.
Publicado: (2012)

Prognostic gene network modules in breast cancer hold promise
por: Teschendorff, Andrew E, et al.
Publicado: (2010)

When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
por: Creighton, Chad J, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_o6trbecij4ep1c818lkhfficd6